Efficacy and pharmacokinetics study of erlotinib in patients with non-small cell lung cancer

Trial Profile

Efficacy and pharmacokinetics study of erlotinib in patients with non-small cell lung cancer

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 18 May 2016

At a glance

  • Drugs Erlotinib (Primary)
  • Indications Non-small cell lung cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 May 2016 Status changed from recruiting to active, no longer recruiting.
    • 15 Apr 2015 Planned number of patients changed from 50 to 70 as reported by University Hospital Medical Information Network - Japan.
    • 19 Mar 2014 Status changed from not yet recruiting to recruiting University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top